Prostate-specific antigen change in the european randomized study of screening for prostate cancer, section rotterdam
- 1 February 2004
- Vol. 63 (2) , 316-320
- https://doi.org/10.1016/j.urology.2003.09.028
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Different PSA Assays Lead to Detection of Prostate Cancers with Identical Histological FeaturesEuropean Urology, 2002
- Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancerUrology, 2002
- Correlation of Initial PSA Level and Biopsy Features with PSA-Doubling Time in Early Stage Prostate Cancers in Japanese MenEuropean Urology, 2002
- PSA doubling time of prostate carcinoma managed with watchful observation aloneInternational Journal of Radiation Oncology*Biology*Physics, 2001
- PROSTATE SPECIFIC ANTIGEN VARIATION IN PATIENTS WITHOUT CLINICALLY EVIDENT PROSTATE CANCERJournal of Urology, 1999
- Evaluation of prostate‐specific antigen, digital rectal examination and transrectal ultrasonography in population‐based screening for prostate cancer: improving the efficiency of early detectionBritish Journal of Urology, 1997
- Physiological Variation of Serum Prostate Specific Antigen in the 4.0 to 10.0 ng./ml. Range in Male VolunteersJournal of Urology, 1996
- Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening populationUrology, 1996
- Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocityUrology, 1995
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992